Head-to-head comparison of three vaccination strategies based on DNA and raw insect-derived recombinant proteins against Leishmania.
Parasitic diseases plague billions of people among the poorest, killing millions annually, and causing additional millions of disability-adjusted life years lost. Leishmaniases affect more than 12 million people, with over 350 million people at risk. There is an urgent need for efficacious and cheap...
Main Authors: | Felicitat Todolí, Alhelí Rodríguez-Cortés, María Del Carmen Núñez, Márcia D Laurenti, Silvia Gómez-Sebastián, Fernando Rodríguez, Eva Pérez-Martín, José M Escribano, Jordi Alberola |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3517401?pdf=render |
Similar Items
-
Compartmentalized Immune Response in Leishmaniasis: Changing Patterns throughout the Disease.
by: Alhelí Rodríguez-Cortés, et al.
Published: (2016-01-01) -
Immuno-metabolic profile of human macrophages after Leishmania and Trypanosoma cruzi infection.
by: Maureen C Ty, et al.
Published: (2019-01-01) -
Sirolimus enhances the protection achieved by a DNA vaccine against Leishmania infantum
by: Alba Martínez-Flórez, et al.
Published: (2020-06-01) -
Transcription of Toll-Like Receptors 2, 3, 4 and 9, FoxP3 and Th17 Cytokines in a Susceptible Experimental Model of Canine Leishmania infantum Infection.
by: Shazia Hosein, et al.
Published: (2015-01-01) -
The head direction circuit of two insect species
by: Ioannis Pisokas, et al.
Published: (2020-07-01)